PADI4 and breast cancer: ZD-E-1M selectively inhibited the PAD4 enzyme in vitro with an IC50 of 2.39 μM and demonstrated strong antitumor and anti-metastatic effects (effective dose: 5 μmol/kg) in a mouse 4T1 breast cancer model [74].